Journal of Education, Health and Sport

With the aim to determine the features of the concentration of C-reactive protein in the blood in carrageenan secondary chronic inflammation on the background of blockade of substance P an experimental prospective controlled randomized study was performed on 132 WAG rats in series of 6 rats each in the natural course and using a pharmacological aprepitant praparation – inhibitor of NK-1R in the control and simulated inflammation series for 6 hours, as well as 1, 2, 3, 5, 7, 10, 14, 21, 28 days. the peculiarities of the concentration of C-reactive protein in the blood in carrageenan secondary chronic inflammation on the background of blockade of substance P have been developed.

Kinobe, R. T., & Miyake, Y. (2020). Evaluating the anti-inflammatory and analgesic properties of maropitant: A systematic review and meta-analysis. Veterinary Journal (London, England: 1997), 259–260, 105471. https://doi.org/10.1016/j.tvjl.2020.105471

Graefe, S., & Mohiuddin, S. S. (2020). Biochemistry, Substance P. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK554583/

Rychlik, A., Gonkowski, S., Makowska, K., Kaczmar, E., & Calka, J. (2020). Changes in the expression of substance P in nerve fibres of the colonic mucosa in dogs suffering from inflammatory bowel disease. Acta Veterinaria Hungarica, 68(2), 154–159. https://doi.org/10.1556/004.2020.00028

Hodo, T. W., de Aquino, M. T. P., Shimamoto, A., & Shanker, A. (2020). Critical Neurotransmitters in the Neuroimmune Network. Frontiers in Immunology, 11, 1869. https://doi.org/10.3389/fimmu.2020.01869

Barbosa-Cobos, R. E., Lugo-Zamudio, G., Flores-Estrada, J., Becerril-Mendoza, L. T., Rodríguez-Henríquez, P., Torres-González, R., Moreno-Eutimio, M. A., Ramirez-Bello, J., & Moreno, J. (2018). Serum substance P: An indicator of disease activity and subclinical inflammation in rheumatoid arthritis. Clinical Rheumatology, 37(4), 901–908. https://doi.org/10.1007/s10067-017-3929-6

Cheadle, C. E., Glencross, D. A., & Hawrylowicz, C. M. (2020). Allergens TRP a swITCH to Initiate Type 2 Immunity. Immunity, 53(5), 900–902. https://doi.org/10.1016/j.immuni.2020.10.019

Schreiber, U., Engl, C., Bayer, M., & König, S. (2020). Labeled substance P as a neuropeptide reporter substance for enzyme activity. Journal of Pharmaceutical and Biomedical Analysis, 178, 112953. https://doi.org/10.1016/j.jpba.2019.112953

Schreiber, U., Engl, C., Bayer, M., & König, S. (2020). Neuropeptide reporter assay for serum, capillary blood and blood cards. MethodsX, 7, 100985. https://doi.org/10.1016/j.mex.2020.100985

Feickert, M., & Burckhardt, B. B. (2020). Mass spectrometric studies on the peptide integrity of substance P and related human tachykinins in human biofluids. Peptides, 170458. https://doi.org/10.1016/j.peptides.2020.170458

Feickert, M., & Burckhardt, B. B. (2020). Validated mass spectrometric assay for the quantification of substance P and human hemokinin-1 in plasma samples: A design of experiments concept for comprehensive method development. Journal of Pharmaceutical and Biomedical Analysis, 191, 113542. https://doi.org/10.1016/j.jpba.2020.113542

Slaats, J., Ten Oever, J., van de Veerdonk, F. L., & Netea, M. G. (2016). IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLoS Pathogens, 12(12), e1005973. https://doi.org/10.1371/journal.ppat.1005973

Ji, A.-L., Liu, Z.-H., Chen, W.-W., & Huang, W.-J. (2016). The clinical significance of level changes of hs-CRP, IL-10 and TNF for patients with MS during active and relieving period. European Review for Medical and Pharmacological Sciences, 20(20), 4274–4276.

Del Giudice, M., & Gangestad, S. W. (2018). Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain, Behavior, and Immunity, 70, 61–75. https://doi.org/10.1016/j.bbi.2018.02.013

Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020). What does plasma CRP tell us about peripheral and central inflammation in depression? Molecular Psychiatry, 25(6), 1301–1311. https://doi.org/10.1038/s41380-018-0096-3

Uciechowski, P., & Dempke, W. C. M. (2020). Interleukin-6: A Masterplayer in the Cytokine Network. Oncology, 98(3), 131–137. https://doi.org/10.1159/000505099

Nasirzade, J., Kargarpour, Z., Hasannia, S., Strauss, F. J., & Gruber, R. (2020). Platelet-rich fibrin elicits an anti-inflammatory response in macrophages in vitro. Journal of Periodontology, 91(2), 244–252. https://doi.org/10.1002/JPER.19-0216

Grossi, V., Gulli, F., Infantino, M., Stefanile, A., Napodano, C., Benucci, M., Pocino, K., Li Gobbi, F., Damiani, A., Di Pino, A., Manfredi, M., Marino, M., Basile, V., Rapaccini, G. L., & Basile, U. (2020). The Laboratory Role in anti-TNF Biological Therapy Era. Immunological Investigations, 49(3), 317–332. https://doi.org/10.1080/08820139.2019.1637434

Fang, D., & Zhu, J. (2020). Molecular switches for regulating the differentiation of inflammatory and IL-10-producing anti-inflammatory T-helper cells. Cellular and Molecular Life Sciences: CMLS, 77(2), 289–303. https://doi.org/10.1007/s00018-019-03277-0

Klymenko, M., Tatarko, S., Shevchenko, O., & Hubina-Vakulyk, G. (2007). Substantiation of the model of chronic (secondary chronic) inflammation. Experimental and Clinical Medicine, 2, 24–28.

Lim, R., Morrill, J. M., Prushik, S. G., Reed, K. L., Gower, A. C., Leeman, S. E., Stucchi, A. F., & Becker, J. M. (2008). An FDA Approved Neurokinin-1 Receptor Antagonist is Effective in Reducing Intraabdominal Adhesions when Administered Intraperitoneally, But Not Orally. Journal of Gastrointestinal Surgery, 12(10), 1754–1761. https://doi.org/10.1007/s11605-008-0634-4

Patel, M., Valaiyaduppu Subas, S., Ghani, M. R., Busa, V., Dardeir, A., Marudhai, S., & Cancarevic, I. (2020). Role of Substance P in the Pathophysiology of Inflammatory Bowel Disease and Its Correlation With the Degree of Inflammation. Cureus, 12(10), e11027. https://doi.org/10.7759/cureus.11027

Fehér, E., & Altdorfer, K. (2020). Neuroimmunomodulation in the mucosa of the alimentary tract. Orvosi Hetilap, 161(35), 1436–1440. https://doi.org/10.1556/650.2020.31795

Sánchez, P., Sánchez, M. L., Mangas, A., Aguilar, L. Á., & Coveñas, R. (2020). A close neuroanatomical relationship between the enkephalinergic (methionine-enkephalin) and tachykininergic (substance P) systems in the alpaca diencephalon. Folia Histochemica Et Cytobiologica, 58(2), 135–146. https://doi.org/10.5603/FHC.a2020.0007